Pharma

Your Article Summary

See Latest Articles

Myriad Genetics Reports Fiscal 2009 Financial Results
Myriad, 08/26/09

Myriad Genetics, Inc. reported financial results for its fourth quarter and fiscal year ended June 2009. It should be noted that as a result of the successful spin off of the Company's pharmaceutical and research businesses on June 2009, the Company's financial statements include a new line for discontinued operations. The Company has reported as discontinued operations all of the expenses generated by the pharmaceutical and research businesses netted against pharmaceutical and research revenue.

Today in Financial Reports...keeping you current

Receive free subspecialty "5-minute updates" via email

Nabi Biopharmaceuticals Completes Sale of PentaStaph to GlaxoSmithKline PLC
Nabi Biopharmaceuticals, 11/05/09

CPSI Profits Down, Revenue Up
HealthDataManagement, 11/02/09

Antigenics Reports Third Quarter 2009 Financial Results
Antigenics, 11/05/09

See All of Financial Reports